Ranbaxy loses approvals, exclusivity of two drugs in US

In November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news